The 2-Minute Rule for Is ABBV-744 effective for hematologic cancers?
In Phase C, individuals will acquire ABBV-744 and oral navitoclax. In Segment D, members will acquire ABBV-744 and ruxolitinib. Individuals will get treatment right until disorder progression or the individuals are not able to tolerate the study drugs.then market H3K27Ac at this location. Chromatin hyperacetylation could boost the accessibility of